July 9 (Reuters) - Sartorius Stedim Biotech SA STDM.PA:
SIGNS MOU WITH SENSIBLE BIOTECHNOLOGIES TO ADVANCE CELL-BASED MRNA PRODUCTION
COLLABORATION AIMS TO ENABLE CLINICAL-GRADE PRODUCTION OF CELL-BASED MRNA BY 2026
Source text: here
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.